Her primary scientific interests are in Internal medicine, Schizophrenia, Endocrinology, Neuroscience and Bioinformatics. Her work deals with themes such as Proteome, Peripheral, Psychosis, Proteomics and Pathology, which intersect with Schizophrenia. She combines subjects such as Prefrontal cortex, Neurodegeneration and Human brain with her study of Endocrinology.
Her Neuroscience study combines topics from a wide range of disciplines, such as Glutamate receptor, Regulation of gene expression and Gene expression profiling. Her Bioinformatics research is multidisciplinary, incorporating elements of Psychological intervention, Immunology and Antipsychotic. Her studies deal with areas such as Major depressive disorder, Pathophysiology and Drug treatment as well as Bipolar disorder.
Her main research concerns Schizophrenia, Internal medicine, Proteomics, Bioinformatics and Endocrinology. Her Schizophrenia study integrates concerns from other disciplines, such as Bipolar disorder, Psychosis, Neuroscience and Disease. Her work in Internal medicine covers topics such as Major depressive disorder which are related to areas like Clinical psychology.
The concepts of her Proteomics study are interwoven with issues in Proteome, Computational biology and Metabolomics. Her Bioinformatics research integrates issues from Immune system and Antipsychotic. Her research integrates issues of Blood serum, Immunology and Pathology in her study of Biomarker.
Internal medicine, Schizophrenia, Major depressive disorder, Biomarker and Bipolar disorder are her primary areas of study. Her studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Anxiety. The Schizophrenia study combines topics in areas such as Toxoplasma gondii, Neuroscience and Disease, Pathology.
Her Neuroscience research is multidisciplinary, relying on both Psychosis, Autism and Proteomic Profiling. Her Major depressive disorder study combines topics in areas such as Mental health and Clinical psychology. The various areas that Sabine Bahn examines in her Biomarker study include Schizophrenia, Physiology, Bioinformatics and Pharmacology.
Her primary scientific interests are in Schizophrenia, Internal medicine, Biomarker, Immunology and Anxiety. When carried out as part of a general Schizophrenia research project, her work on Antipsychotic treatment is frequently linked to work in Association, therefore connecting diverse disciplines of study. Her research in Internal medicine intersects with topics in Bipolar disorder, Endocrinology and Oncology.
In general Endocrinology study, her work on Malondialdehyde often relates to the realm of Isoprostane, thereby connecting several areas of interest. Her biological study spans a wide range of topics, including Oxidative stress, Disease and Physiology. Her research investigates the link between Immunology and topics such as Antipsychotic that cross with problems in Positive and Negative Syndrome Scale, Neuregulin, Schizophrenia and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
S. Prabakaran;S. Prabakaran;J. E. Swatton;J. E. Swatton;M. M. Ryan;M. M. Ryan;S. J. Huffaker;S. J. Huffaker.
Molecular Psychiatry (2004)
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Dmitri Tkachev;Michael L Mimmack;Michael L Mimmack;Margaret M Ryan;Margaret M Ryan;Matt Wayland.
The Lancet (2003)
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.
Georgia E. Hodes;Madeline L. Pfau;Marylene Leboeuf;Sam A. Golden.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Kainate receptor gene expression in the developing rat brain
S Bahn;B Volk;W Wisden.
The Journal of Neuroscience (1994)
Ligand-Gated Ion Channel Subunit Partnerships: GABAAReceptor α6 Subunit Gene Inactivation Inhibits δ Subunit Expression
A. Jones;E. R. Korpi;R. M. McKernan;R. Pelz.
The Journal of Neuroscience (1997)
Transcriptional neoteny in the human brain
Mehmet Somel;Henriette Franz;Zheng Yan;Anna Lorenc.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.
Elaine Holmes;Tsz M Tsang;Jeffrey T.-J Huang;F. Markus Leweke.
PLOS Medicine (2006)
Identification of a Biological Signature for Schizophrenia in Serum
E Schwarz;P C Guest;H Rahmoune;L W Harris.
Molecular Psychiatry (2012)
Gene expression profiling in the adult Down syndrome brain
H.E. Lockstone;L.W. Harris;J.E. Swatton;M.T. Wayland.
Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22
Michael L. Mimmack;Margaret Ryan;Hajime Baba;Juani Navarro-Ruiz.
Proceedings of the National Academy of Sciences of the United States of America (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: